Trials / Unknown
UnknownNCT02870036
Study to Evaluate the Safety, Tolerability, Preliminary Efficacy and Pharmacokinetics of Simmitecan Monotherapy and Combination in Patients With Advanced Solid Tumors
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 243 (estimated)
- Sponsor
- Haihe Biopharma Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the safety, tolerability, preliminary efficacy and pharmacokinetics of Simmitecan in patients with advanced solid tumors and Simmitecan, 5-fluorouracil and Leucovorin Calcium,thalidomide in patients with advanced solid tumor or advanced/metastatic colorectal cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Simmitecan | |
| DRUG | 5-fluorouracil and Leucovorin Calcium | |
| DRUG | Thalidomide |
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2020-12-01
- Completion
- 2020-12-01
- First posted
- 2016-08-17
- Last updated
- 2017-07-14
Locations
9 sites across 1 country: China
Source: ClinicalTrials.gov record NCT02870036. Inclusion in this directory is not an endorsement.